CareDx, Inc.
CDNA
$43.71
+14.72%
Related headlines
CDNA price trend
Wall Street consensus
Most Wall Street analysts maintain a constructive view on CareDx, Inc.'s 12-month outlook, with a consensus price target around $35.40 and implied upside of -19.0% versus the current price.
Average Target
$35.40
0 analysts
Implied Upside
-19.0%
vs. current price
Analyst Count
—
covering this stock
Price Range
$21 - $50
Analyst target range
CDNA Technical Analysis
Beta
—
—
Max Drawdown
-43.9%
Largest decline past year
52-Week Range
$11-$45
Price range past year
Annual Return
+255.8%
Cumulative gain past year
| Period | CDNA Return | S&P 500 |
|---|---|---|
| 1m | +49.4% | +0.2% |
| 3m | +103.3% | +3.7% |
| 6m | +112.7% | +8.0% |
| 1y | +255.8% | +18.2% |
| ytd | +128.4% | +9.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
Valuation Analysis: Is CDNA Overvalued?
PE
-47.1x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-1446.3x
Enterprise Value Multiple